Zhongchao Announces Resignation of Three Senior Officers Amid Strategy Shift

Zhongchao ( (ZCMD) ) has issued an update.

Zhongchao Inc. reported that on March 15, 2026, it accepted the immediate resignations of three senior officers as part of an adjustment to its business strategies. Chief Medical Officer Xuejun Chen, Chief Sales Officer Baoqian Tian and Chief Operating Officer Shuang Wu all left their roles, with the company stating their departures did not stem from disagreements over operations, policies or practices.

The simultaneous exit of key medical, sales and operating leaders underscores a significant leadership reshuffle tied to Zhongchao’s strategic realignment. While the company emphasized an absence of internal conflict, the move could signal a notable shift in operational priorities and may prompt investors and other stakeholders to watch closely how management responsibilities are restructured following these departures.

Spark’s Take on ZCMD Stock

According to Spark, TipRanks’ AI Analyst, ZCMD is a Neutral.

Zhongchao’s overall stock score is low primarily due to significant financial struggles, including negative cash flows and net losses. Technical analysis indicates a bearish trend, further weighing on the stock. Valuation metrics are also unfavorable, with a negative P/E ratio and no dividend yield, suggesting limited investor appeal at present.

To see Spark’s full report on ZCMD stock, click here.

More about Zhongchao

Zhongchao Inc. is a China-based company listed in the United States and categorized as a foreign private issuer under SEC rules. The company files annual reports on Form 20-F and maintains multiple active registration statements, indicating ongoing access to U.S. capital markets for share-based compensation and potential securities offerings.

Average Trading Volume: 215,085

Technical Sentiment Signal: Sell

Current Market Cap: $6.07M

For detailed information about ZCMD stock, go to TipRanks’ Stock Analysis page.